药易购(300937.SZ)：第三季度净亏损74.21万元

Core Viewpoint - The company reported a year-on-year increase in revenue for Q3 2025, but net profit remains negative, indicating potential challenges in profitability despite revenue growth [1] Financial Performance - The company's operating revenue for Q3 2025 was 1.085 billion, representing a year-on-year increase of 7.41% [1] - The net profit attributable to shareholders was -742,100, indicating a loss [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -1.8295 million, further highlighting profitability issues [1]